MedTech Acquisition
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of MedTech Acquisition generated cash of -$50,045,000, which is less than the previous year. Cash used in financing activities reached the amount of $54,629,000 last year. Net change in cash is therefore $2,463,000.

Cash Flow

MedTech Acquisition Corporation (NASDAQ:MTAC): Cash Flow
2020 -15.58M -9.70M 24.80M
2021 -22.69M -2.25M 50.76M
2022 -32.31M -1.78M 13.46M
2023 -50.04M -2.12M 54.62M

MTAC Cash Flow Statement (2020 – 2023)

2023 2022 2021 2020
Cash at beginning of period
9.66M30.30M4.48M4.96M
Operating activities
Net income
-59.03M-47.18M-28.84M-31.83M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
702K398K464K321K
Stock-based compensation expense
1.40M368K109K22K
Deferred income tax benefit 1.40M368K109K22K
Changes in operating assets and liabilities:
Accounts receivable, net
-1.97M-200K-741K-423K
Inventories
-1.07M-179K-725K755K
Accounts payable
2.83M5.24M3.17M0
Cash generated by operating activities
-50.04M-32.31M-22.69M-15.58M
Investing activities
Purchases Of Investments
0000
Investments In Property Plant And Equipment
-588K-786K-1.25M-545K
Acquisitions Net
0-1M-1M0
Cash generated by investing activities
-2.12M-1.78M-2.25M-9.70M
Financing activities
Common Stock Issued
17.88M13.59M00
Payments for dividends
0000
Repurchases of common stock
-20K000
Repayments of term debt
-87K-131K-1.34M-24.77M
Cash used in financing activities
54.62M13.46M50.76M24.80M
Net Change In Cash
2.46M-20.63M25.81M-477K
Cash at end of period
12.12M9.66M30.30M4.48M